Calyxt Inc CLXT:NASDAQ

Last Price$6.39NASDAQ Previous Close - Last Trade as of 4:00PM ET 2/14/20

Today's Change0(0.00%)
Bid (Size)$6.38 (2)
Ask (Size)$6.39 (7)
Day Low / HighN/A - N/A
Volume77.3 K
 

View Miscellaneous Commercial Services IndustryPeer Comparison as of 02/14/2020

 

Calyxt Inc ( NASDAQ )

Price: $6.39
Change: -0.02 (0.31%)
Volume: 77.3 K
4:00PM ET 2/14/2020
 
 

Select Interior Concepts Inc ( NASDAQ )

Price: $8.43
Change: -0.07 (0.82%)
Volume: 58.7 K
4:00PM ET 2/14/2020
 
 

Exicure Inc ( NASDAQ )

Price: $2.38
Change: -0.01 (0.42%)
Volume: 175.2 K
4:00PM ET 2/14/2020
 
 

Universal Technical Institute Inc ( NYSE )

Price: $9.27
Change: -0.03 (0.32%)
Volume: 187.0 K
3:59PM ET 2/14/2020
 
 

GP Strategies Corp ( NYSE )

Price: $14.58
Change: +0.73 (5.27%)
Volume: 62.2 K
6:30PM ET 2/14/2020
 

Read more news Recent News

Cellectis Discloses in Regulatory Filing 69.1% Ownership in Calyxt
2:01PM ET 9/23/2019 MT Newswires

Cellectis S.A (CLLS) said in a regulatory filing it beneficially owns about 22.7 million shares -- or roughly 69.1% -- of Calyxt, Inc.'s (CLXT) total...

Calyxt Strikes Seed Deal with Landus Cooperative
4:57PM ET 9/19/2019 MT Newswires

Calyxt (CLXT), a food ingredients company, said on Thursday it has struck a deal to add Landus Cooperative's seed distribution, agronomy support, grain...

Calyxt Files Shelf Registration Statement for Sale of Up to $200 Million Worth of Securities
4:25AM ET 9/17/2019 MT Newswires

Calyxt (CLXT), a food products company, late Monday filed a mixed shelf registration statement for the sale of up to $200 million worth of securities. The...

Calyxt Posts Wider-Than-Expected Q2 Loss
4:02AM ET 8/07/2019 MT Newswires

Calyxt (CLXT), a Minnesota-based food ingredients company, on Tuesday reported Q2 loss of $0.29 per share, compared with loss of $0.25 in the year-ago...

Company Profile

Business DescriptionCalyxt, Inc. operates as a healthy food ingredient company. It engages in the development of crops by leveraging processes that occur in nature, combining its gene-editing technology and technical expertise with its commercial strategy to bring healthier ingredients to the market. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN. View company web site for more details
Address2800 Mount Ridge Road
Roseville, Minnesota 55113
Phone+1.651.683.2807
Number of Employees50
Recent SEC Filing02/07/2020SC 13G/A
Chief Executive OfficerJames A. Blome
Chief Financial OfficerWilliam F. Koschak
Chief Science OfficerDaniel F. Voytas
Chief Technology OfficerTravis Frey

Company Highlights

Price Open$6.38
Previous Close$6.41
52 Week Range$3.55 - 19.30
Market Capitalization$210.6 M
Shares Outstanding33.0 M
SectorCommercial Services
IndustryMiscellaneous Commercial Services
Next Earnings Announcement03/05/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.10
Beta vs. S&P 500N/A
Revenue$236.0 K
Net Profit Margin-1,016.27%
Return on Equity-43.09%

Analyst Ratings as of 12/03/2019

Buy
6
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset